2022年热门期刊有哪些?梅斯热门指数告诉您答案

2022-02-14 MedSci原创 MedSci原创

想到热门期刊,大家最熟悉应该是Plos One, Sci rep这些开源期刊,曾经每年能发表数万篇文章,一时无两!

想到热门期刊,大家最熟悉应该是Plos One, Sci rep这些开源期刊,曾经每年能发表数万篇文章,一时无两!

然而,随着各个大学或医院出台预警期刊,以及有一些基金评审时,不再相信这些期刊上发表的论文之后,不少期刊热度直线下降。具体查询热度,梅斯医学的“热门指数”是最可靠的指标,大家可以看看Plos one:PLoS One-MedSci指数,顶盛时期在2019年。

那么,大家知道2022年度最热门的期刊有哪些吗?当然,这里梅斯小编也要提醒大家一句,过度热门,就很容易成为水刊!很容易被预警!当年Oncotarget,一夜之间冲起来,后面大家知道命运了!

下面小编给大家说出2022年度最热的20大期刊(既是机会,也是陷阱)

Frontiers in Oncology
medicine
Scientific Reports
PLoS One
Cell Death & Disease,华人任主编以后就是不一样!
Frontiers in Pharmacology
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Frontiers in Immunology
Biomed Research International
Frontiers in Cell and Developmental Biology
Frontiers in Genetics
World Journal of Clinical Cases  大量病例报道的最终出处
Evidence-based Complementary and Alternative Medicine 中西医结合领域神刊
Frontiers in Medicine
Cancer Medicine
Bioengineered
BMC CANCER
Frontiers in Cardiovascular Medicine
Annals of Translational Medicine

从上面列表中可以看出,medicine,Scientific Reports,PLoS One三大经典OA刊物之外,出现了大量“热门期刊”,尤其是Frontiers系列冲得特别靠前,难怪要被不少医院预警,也不无道理。

这里面未来会冒出很多“水刊”!当然,有人说,水刊如何定义?Nature communication是水刊吗?当然不是!虽然国人发表的文章数量也极为庞大,但是水准之高。从目前梅斯热门指数来看,热门指数超过100,沦为水刊的概率极高!Nature communication曾经一度冲过80左右,但是近年来持续下跌,期刊进入良性循环。

另外,哪些新刊热度快速上升呢?如果是新刊,热度上升,表明很容易投稿的。下面是

Frontiers in Oncology
Frontiers in Pharmacology
Frontiers in Immunology
Frontiers in Cell and Developmental Biology
Frontiers in Genetics
World Journal of Clinical Cases
Frontiers in Medicine
Cancer Medicine
Frontiers in Cardiovascular Medicine
Annals of Translational Medicine
Cell Death Discovery
Cancer Management and Research
International Journal of General Medicine
Translational Cancer Research
EBioMedicine
PeerJ
Advanced Science
Cancers
Frontiers in Endocrinology
Journal of Clinical Medicine

对于超新刊,即刚刚进入梅斯医学数据库的,又有哪些热门期刊呢?这里期刊,相信大家大多数都不熟悉,但是值得尝试

Frontiers in Cardiovascular Medicine
International Journal of General Medicine
Laryngoscope Investigative Otolaryngology
iScience
Frontiers in Surgery
Frontiers in Nutrition
Heliyon
Journal of Clinical and Translational Hepatology
Journal of Pharmaceutical Research International
Nature Cancer
Nature Aging
Nature Food
All Life
Hepatology Communications
Nature metabolism
Horticultural Plant Journal
Frontiers in Environmental Science
Journal of Translational Internal Medicine
Infectious Diseases and Therapy
ESMO Open

这些超新星,往往都是新刊,稿源并不充足。你不知道,其实很多研究者跟你一样,也不知道,你若试一试,运气可能就来了。不过,放眼一看,Frontiers系列仍然生猛!

另外,还有5年热门指数可以参考,以及热门指数曲线,可以一目了然热门发展变化趋势,希望大家都能抓住期刊的趋势与特点,梅斯小编只能帮您到这里了,更多的靠您自己探索了。

当然,上面仅仅是针对梅斯热门指数解析的一点点,您仔细看看热门指数,你可能还能明白很多!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1277325, encodeId=6bc812e7325a2, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 16 03:57:03 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193418, encodeId=9726119341848, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Feb 14 22:16:13 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-16 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1277325, encodeId=6bc812e7325a2, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 16 03:57:03 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193418, encodeId=9726119341848, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Feb 14 22:16:13 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 医者仁者

    学习了

    0